DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Artículo científico (JournalArticle)
The cell biology behind the oncogenic PIP3 lipids
The different mechanisms of phosphoinositide 3-kinase (PI3K) activation in cancer as well as the events that result in PI3K pathway reactivation after patient treatment with PI3K inhibitors was discussed on October 15–17th, 2018, in the medieval town of Baeza (Universidad Internacional de Andalucía, Spain) at the workshop entitled ‘The cell biology behind the oncogenic PIP3 lipids’. These topics and the data presented regarding cellular functions altered by PI3K deregulation, the cooperation of PI3K/PTEN mutations with other tumor drivers, and the lessons learned for PI3K-targeted therapy, are discussed below., Work in the group of ACC is financed by grants from the Ministerio de Ciencia e Innovación (Spanish Ministry of Science and Innovation; SAF2016-79195), the Madrid regional government (BMD-3804), the Fundación Ramón Areces and the Fundación Científica Asociación Española Contra el Cáncer (16035CARR).